https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-82002-10-29 00:00:002019-02-15 08:53:33Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-62002-10-01 00:00:002002-10-01 00:00:00Dendritic cells in vaccination therapies of malignant diseases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Clin. Exp. Immunol. 2002 Oct;130(1):107-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Clin. Exp. Immunol. 2002 Oct;130(1):107-142002-10-01 00:00:002019-02-15 08:37:56Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12
